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The JCSG has recently developed a protocol for systematic comparisons ofhigh-
quality crystal and NMR structures of proteins. In this paper, the extent to which
this approach can provide function-related information on the two functionally
annotated proteins TM1081, a Thermotoga maritima anti-  factor antagonist,
and A2LD1 (gi:13879369), a mouse  -glutamylamine cyclotransferase, is
explored. The NMR structures of the two proteins have been determined in
solution at 313 and 298 K, respectively, using the current JCSG protocol based
on the software package UNIO for extensive automation. The corresponding
crystal structures were solved by the JCSG at 100 K and 1.6 A ˚ resolution and at
100 K and 1.9 A ˚ resolution, respectively. The NMR and crystal structures of the
two proteins share the same overall molecular architectures. However, the
precision of the structure determination along the amino-acid sequence varies
over a signiﬁcantly wider range in the NMR structures than in the crystal
structures. Thereby, in each of the two NMR structures about 65% of the
residues have displacements below the average and in both proteins the less well
ordered residues include large parts of the active sites, in addition to some highly
solvent-exposed surface areas. Whereas the latter show increased disorder in the
crystal and in solution, the active-site regions display increased displacements
only in the NMR structures, where they undergo local conformational exchange
on the millisecond time scale that appears to be frozen in the crystals. These
observations suggest that a search for molecular regions showing increased
structural disorder and slow dynamic processes in solution while being well
ordered in the corresponding crystal structure might be a valid initial step in
the challenge of identifying putative active sites in functionally unannotated
proteins with known three-dimensional structure.
1. Introduction
A recently introduced JCSG protocol for systematic comparisons of
NMR and crystal structures (Jaudzems et al., 2010; Mohanty et al.,
2010) is used with two functionally annotated proteins: the anti- 
factor antagonist TM1081 from Thermotoga maritima and the
Mus musculus  -glutamylamine cyclotransferase A2LD1 (GGACT;
gi:13879369). In an attempt to exploit the complementarity of NMR
spectroscopy and X-ray crystallography in providing function-related
information, we explore the combined use of the two structure-
determination techniques for initial identiﬁcation of putative active
sites in proteins of unknown function.
TM1081 is annotated as an anti-  factor antagonist based on
sequence similarity to members of the STAS (sulfate transporter and
anti-  factor antagonist) Pfam family (PF01740). This domain, which
is often found in the C-terminal region of sulfate transporters and
bacterial anti-  factor antagonists, may have a general NTP-binding
function (Aravind & Koonin, 2000). TM1081 shares more than 30%
sequence identity with its Thermotogae, Spirochaetes and Actino-
bacteria counterparts, which possess the anticipated anti-  factor
antagonist fold (Seavers et al., 2001; Masuda et al., 2004; Lee et al.,2004), indicating that the Thermotoga protein may also be involved
in transcriptional regulation of gene expression as part of cell-
adaptation mechanisms that are mediated by a variety of stress-
response signals. The TM1081 crystal structure has been determined
by the JCSG (PDB entry 3f43).
When the crystal structure of the mouse protein A2LD1
(gi:13879369) was determined by the JCSG (PDB entry 1vkb), it was
a ‘domain of unknown function’ and classiﬁed as a new fold (Klock et
al., 2005). This protein belongs to the highly conserved Pfam AIG2
family (PF03674), which includes hundreds of members from all
kingdoms of life, and was subsequently annotated as an AIG2-like
domain-containing protein-1. Recently, human  -glutamylamine
cyclotransferase (GCACT) was structurally (PDB code 3jud) and
biochemically characterized based on homology with the JCSG
mouse homolog structure (Oakley et al., 2010). The proteins share
72% sequence identity and adopt very similar structures, including a
conserved catalytic site, strongly indicating that the mouse protein is
also a  -glutamylamine cyclotransferase.
Here, we describe NMR structure determinations of TM1081 and
A2LD1 using the current JCSG protocol, which makes use of the
UNIO software package for extensive automation (Herrmann et al.,
2002a,b;V o l ket al., 2008; Fiorito et al., 2008). For comparison of the
newly determined NMR structures with the aforementioned crystal
structures, we continue to explore the recently introduced strategy of
using ‘reference crystal structures’ (RefCrystal) and ‘reference NMR
structures’ (RefNMR) (Jaudzems et al., 2010) to analyze and support
the identiﬁcation of structure variations that arise from the different
environments in the crystal and in solution rather than from the
different structure-determination techniques.
2. Methods and experiments
2.1. Preparation of TM1081
The vector MH4a containing the TM1081 gene with an N-terminal
expression and polyhistidine puriﬁcation tag was cloned by the JCSG
Crystallomics Core and used to produce the proteins for both the
NMRand crystal structure determinations. For NMRstudies,
15N,
13C-
labeled TM1081 was expressed using Escherichia coli strain Rosetta
(DE3) (Novagen) and M9 minimal media containing either 1 g l
 1
15NH4Cl and 4 g l
 1 unlabeled d-glucose or 1 g l
 11 5 NH4Cl and
4gl
 1 [
13C6]-d-glucose (Cambridge Isotope Laboratories) as the sole
sources of nitrogen and carbon. After the addition of 100 mg l
 1
ampicillin and 20 mg l
 1 chloramphenicol, the cells were grown at
310 K to an OD600 of 0.64, induced with 1 mM isopropyl  -d-1-
thiogalactopyranoside (IPTG) and grown for a further 3.5 h to a ﬁnal
OD600 of 1.15. The cells were harvested by centrifugation at 5000g for
5 min at 277 K and frozen at 253 K overnight. The next day, the cell
pellet was thawed and resuspended in 53 ml buffer A (20 mM sodium
phosphate pH 7.4, 300 mM NaCl, 30 mM imidazole) containing one
Complete EDTA-free protease-inhibitor cocktail tablet (Roche) and
lysed by ultrasonication. The soluble fraction of the cell lysate was
isolated by centrifugation at 20 000g for 30 min at 277 K, decanted
and ﬁltered through a 0.22 mm ﬁlter. The solution was then incubated
in a 348 K water bath for 30 min. The precipitated material was
removed by centrifugation at 8000g for 30 min at 277 K. The super-
natant was recovered and passed through the 0.22 mm ﬁlter before
application onto a 5 ml HisTrap HP column (GE Healthcare) pre-
equilibrated in buffer A. The bound protein was eluted using a linear
30–500 mM imidazole gradient over a 100 ml volume. Fractions
containing the protein were pooled and applied onto a HiLoad 26/60
column of Superdex 75 gel-ﬁltration resin (GE Healthcare) pre-
equilibrated in NMR buffer (20 mM sodium phosphate pH 5.7,
150 mM NaCl). The fractions containing TM1081 were pooled and
concentrated from 24 ml to 500 ml by ultraﬁltration using an Amicon
ultracentrifugal ﬁlter device with 5 kDa molecular-weight cutoff
(Millipore). All puriﬁcation steps were monitored by SDS–PAGE.
The yield of puriﬁed TM1081 was 14.9 mg per litre of culture.
NMR samples were prepared by adding 5%(v/v)D 2O and
0.03%(w/v) NaN3 to 500 mlo fa1 . 0m M solution of
15N,
13C-labeled
TM1081 in NMR buffer.
2.2. Preparation of A2LD1
The plasmid vector MH4a-A2LD1 (gi:13879369) obtained from
the JCSG Crystallomics Core was used as the template for PCR
ampliﬁcation with the primers 50-CCGCATATGGCCCACATCTTC-
GTGTATGGCA-30 and 50-CGGAAGCTTCTATTATCTGTTTTCC
CGGGGGTTGTAGCG-30, where the NdeI and HindIII restriction
sites are shown in bold and the initiation and stop codons are itali-
cized. The PCR product was digested with NdeI and HindIII and
inserted into the same restriction sites of the pET-25b vector after
treatment with calf intestinal alkaline phosphatase (CIP). The
resulting plasmid pET-25b-gi:13879369 was used to transform E. coli
strain Rosetta (DE3) (Novagen) and the protein was expressed in M9
minimal media containing either 1 g l
 11 5 NH4Cl and 4 g l
 1 un-
labeled d-glucose or 1 g l
 11 5 NH4Cl and 4 g l
 1 [
13C6]-d-glucose
(Cambridge Isotope Laboratories) as the sole sources of nitrogen and
carbon. After the addition of 100 mg l
 1 ampicillin, the cells were
grown at 310 K to an OD600 of 0.44, induced with 1 mM isopropyl
 -d-1-thiogalactopyranoside (IPTG) and grown for a further 3 h to a
ﬁnal OD600 of 0.87. The cells were harvested by centrifugation at
5000g for 5 min at 277 K and frozen at 253 Kovernight. The next day,
the cell pellet was thawed and resuspended in 38 ml buffer B (25 mM
sodium phosphate at pH 7.6, 25 mM NaCl, 2 mM DTT) containing
one Complete protease-inhibitor cocktail tablet (Roche) and lysed by
ultrasonication. The soluble fraction of the cell lysate was isolated by
centrifugation at 20 000g for 30 min at 277 K, decanted and ﬁltered
through a 0.22 mm ﬁlter. The solution was then applied onto a 5 ml
HiTrap QHP column (GE Healthcare) pre-equilibrated in buffer B.
Initially, A2LD1 eluted in the second half of the ﬂowthrough during
sample injection. The ﬂowthrough fractions containing A2LD1 were
pooled and again applied onto a 5 ml HiTrap QHP column pre-
equilibrated in buffer B; the protein bound and was subsequently
eluted from the column with 125 mM NaCl. Fractions containing the
protein were concentrated to 10 ml by ultraﬁltration using an Amicon
ultracentrifugal ﬁlter device with 5 kDa molecular-weight cutoff
(Millipore) and were then applied onto a HiLoad 26/60 column of
Superdex 75 gel-ﬁltration resin (GE Healthcare) pre-equilibrated in
NMR buffer (25 mM sodium phosphate pH 6.8, 50 mM NaCl, 0.5 mM
DTT). The fractions containing A2LD1 were pooled and concen-
trated from 60 ml to 500 ml by ultraﬁltration. All puriﬁcation steps
were monitored by SDS–PAGE. The yield of puriﬁed A2LD1 was
32.7 mg per litre of culture.
NMR samples were prepared by adding 10%(v/v)D 2O, 4.5 mM
d-DTT and 0.03%(w/v) NaN3 to 500 mlo fa1 . 1 m M solution of
15N,
13C-labeled A2DL1 in NMR buffer.
2.3. NMR spectroscopy
NMR experiments for the protein TM1081 were conducted at
313 K on Bruker Avance 600 and Avance 800 spectrometers
equipped with TXI HCN z-gradient or xyz-gradient probes and the
measurements for A2DL1 were performed at 298 K using the same
spectrometers. Internal 2,2-dimethyl-2-silapentane-5-sulfonate (DSS)
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the backbone resonance assignments of TM1081, we used a 2D
[
15N,
1H]-HSQC spectrum (Mori et al., 1996) and triple-resonance 3D
HNCA, 3D HNCO, 3D HNCACB and 3D CBCA(CO)NH spectra
(Bax & Grzesiek, 1993). For the side-chain assignments and the
collection of conformational constraints, three NOESY spectra were
recorded with a mixing time of 60 ms: 3D [
1H,
1H]-NOESY-
15N-
HSQC, 3D [
1H,
1H]-NOESY-
13C(ali)-HSQC and 3D [
1H,
1H]-
NOESY-
13C(aro)-HSQC. The
13C carrier frequencies were at 27 and
125 p.p.m., respectively, for coverage of the aliphatic and aromatic
spectral regions. For A2DL1, the backbone resonance assignments
were based on three 600 MHz APSY-NMR data sets, i.e. 4D APSY-
HACANH (38 projections), 5D APSY-HACACONH (22 projec-
tions) and 5D APSY-CBCACONH (24 projections) (Hiller et al.,
2008), and on a low-resolution 3D HNCA spectrum (Bax & Grzesiek,
1993). Side-chain assignments and the collection of conformational
constraints were achieved using the same types of spectra and
following the same procedure as for TM1081. In addition, a 2D
[
15N,
1H]-HSQC spectrum (Mori et al., 1996) and a heteronuclear 2D
[
1H]-NOE TROSY experiment (Zhu et al., 2000) were recorded at
700 MHz on a Bruker DRX spectrometer.
2.4. NMR structure determination
For TM1081, sequence-speciﬁc backbone resonance assignments
were obtained with the program CARA (Keller, 2004) from the
aforementioned triple-resonance experiments. In a second interactive
step, the assignments were extended to the  - and  -protons using the
3D [
1H,
1H]-NOESY-
15N-HSQC and 3D [
1H,
1H]-NOESY-
13C(ali)-
HSQC data sets. Automated analysis of the three standard 3D
heteronuclear-resolved [
1H,
1H]-NOESY data sets with the software
UNIO-ATNOS/ASCAN (Herrmann et al., 2002a; Fiorito et al., 2008)
was then used to obtain amino-acid side-chain assignments.
For A2LD1, the NMR assignments were obtained as described for
TM1081, except that the backbone assignments were extensively
automated, using the three APSY-NMR spectra mentioned in the
preceding sections as input for the software UNIO-MATCH (Volk
et al., 2008) and then validated interactively using the information
contained in a low-resolution 3D HNCA spectrum.
For both proteins, automated structure calculation was performed
using the software UNIO-ATNOS/CANDID (Herrmann et al.,
2002a,b) in combination with the torsion-angle dynamics program
CYANA v.3.0 (Gu ¨ntert et al., 1997). The standard seven-cycle UNIO-
structural communications
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Table 1
Determination of the NMR structure, a reference crystal structure and a reference
NMR structure of the protein TM1081: input for the structure calculations and
characterization of bundles of 20 energy-minimized CYANA conformers
representing the structures.
Except for the top six entries and the Ramachandran plot statistics, average values and
standard deviations for the 20 conformers are given.
NMR
structure†
Reference
crystal
structure‡
Reference
NMR
structure§
NOE upper distance limits 2316 4735 4055
Intra-residual 555 1035 1209
Short-range 603 1112 1075
Medium-range 554 1169 955
Long-range 604 1419 816
Dihedral angle constraints 423 413 447
Residual target-function value (A ˚ 2) 2.53   0.29 1.17   0.27 1.86   0.27
Residual NOE violations
No.   0.1 A ˚ 47   76   26  3
Maximum (A ˚ ) 0.15   0.01 0.14   0.02 0.15   0.06
Residual dihedral angle violations
No.   2.5  0   01   12   1
Maximum ( ) 2.16   0.81 3.45   1.09 3.86   1.37
AMBER energies (kcal mol
 1})
Total  4316   121  4323   92  4327   85
van der Waals  317   15  431   18  333   11
Electrostatic  5138   107  4720   55  4992   98
R.m.s.d. from mean coordinates†† (A ˚ )
Backbone (3–110) 0.61   0.08 0.37   0.06 0.59   0.07
All heavy atoms (3–110) 1.03   0.08 0.71   0.07 0.98   0.08
Backbone (DNMR   0.50 A ˚ ) 0.39   0.07 0.31   0.05 0.35   0.05
All heavy atoms (DNMR   0.50 A ˚ ) 0.77   0.06 0.59   0.06 0.78   0.06
Ramachandran plot statistics‡‡
Most favored regions (%) 71.4 84.8 75.3
Additional allowed regions (%) 23.8 14.7 22.6
Generously allowed regions (%) 3 0.5 2.4
Disallowed regions (%) 1.7 0.0 0.7
† Structure calculated from the experimental NMR data. The top six entries represent
the input generated in the ﬁnal cycle of the ATNOS/CANDID and CYANA
calculation. ‡ Structure calculated with CYANA from conformational constraints
derived from the molecular model representing the crystal structure and subjected to the
same energy minimization as the experimental NMR structure (Jaudzems et al.,
2010). § Structure calculated with CYANA from conformational constraints derived
from the bundle of 20 molecular models representing the NMR structure and subjected
to the same energy minimization as the experimental NMR structure (Jaudzems et al.,
2010). } 1 cal = 4.186 J. †† The numbers in parentheses indicate the residues for
which the r.m.s.d. was calculated. Residues with DNMR   0.50 A ˚ are identiﬁed in
Fig. 1(c). ‡‡ As determined by PROCHECK (Laskowski et al., 1993). The equivalent
anaysis for the crystal structure deposited in the PDB (3f34) results in 90.3% favored,
9.7% additionally allowed, 0% generously allowed and 0% disallowed.
Table 2
Determination of the NMR structure, a reference crystal structure and a reference
NMR structure of the protein A2LD1: input for the structure calculations and
characterization of bundles of 20 energy-minimized CYANA conformers
representing the structures.
Except for the top six entries and the Ramachandran plot statistics, average values and
standard deviations for the 20 conformers are given.
NMR
structure†
Reference
crystal
structure‡
Reference
NMR
structure§
NOE upper distance limits 3175 5557 5111
Intra-residual 615 1088 1301
Short-range 884 1415 1518
Medium-range 446 884 748
Long-range 1230 2170 1544
Dihedral angle constraints 461 502 506
Residual target-function value (A ˚ 2) 2.58   0.31 1.86   0.38 2.31   0.48
Residual NOE violations
No.   0.1 A ˚ 28   51 2   21 1   3
Maximum (A ˚ ) 0.15   0.04 0.19   0.04 0.19   0.01
Residual dihedral angle violations
No.   2.5  0   12   11   1
Maximum ( )2 . 5   1.5 3.3   0.5 3.1   1.4
AMBER energies (kcal mol
 1})
Total  5427   89  5506   71  5142   117
van der Waals  512   24  464   18  377   33
Electrostatic  6276   99  6584   57  6330   97
R.m.s.d. from mean coordinates†† (A ˚ )
Backbone (2–144) 0.65   0.11 0.34   0.05 0.71   0.09
All heavy atoms (2–144) 1.06   0.13 0.70   0.05 1.14   0.09
Backbone (DNMR   0.64 A ˚ ) 0.49   0.06 0.33   0.05 0.54   0.09
All heavy atoms (DNMR   0.64 A ˚ ) 0.84   0.05 0.64   0.05 0.86   0.09
Ramachandran plot statistics‡‡
Most favored regions (%) 76.7 87.0 75.7
Additional allowed regions (%) 21.1 11.8 22.4
Generously allowed regions (%) 1.6 0.6 1.3
Disallowed regions (%) 0.6 0.5 0.5
† Structure calculated from the experimental NMR data. The top six entries represent
the input generated in the ﬁnal cycle of the ATNOS/CANDID and CYANA
calculation. ‡ Structure calculated with CYANA from conformational constraints
derived from the molecular model representing the crystal structure and subjected to the
same energy minimization as the experimental NMR structure (Jaudzems et al.,
2010). § Structure calculated with CYANA from conformational constraints derived
from the bundle of 20 molecular models representing the NMR structure and subjected
to the same energy minimization as the experimental NMR structure (Jaudzems et al.,
2010). } 1 cal = 4.186 J. †† The numbers in parentheses indicate the residues for
which the r.m.s.d. was calculated. Residues with DNMR   0.64 A ˚ are identiﬁed in
Fig. 2(c). ‡‡ As determined by PROCHECK (Laskowski et al., 1993). The equivalent
anaysis for the crystal structure deposited in the PDB (1vkb) results in 99.3% favored,
0.7% additionally allowed, 0% generously allowed and 0% disallowed.ATNOS/CANDID protocol (Herrmann et al., 2002a) was employed
with 80 randomized starting conformers. The 40 conformers with the
lowest residual CYANA target-function values after cycle 7 were
energy-minimized in a water shell with the program OPALp
(Luginbu ¨hl et al., 1996; Koradi et al., 2000) using the AMBER force
ﬁeld (Cornell et al., 1995). The 20 conformers with the lowest target-
function values that satisﬁed the validation criteria (see below) were
selected to represent the NMR structures and were analyzed using
the program MOLMOL (Koradi et al., 1996).
2.5. Structure validation and data deposition
Structure validation was performed as described in Jaudzems et al.
(2010). The chemical shifts were deposited in the BioMagRes Bank
(http://www.bmrb.wisc.edu; entry Nos. 10868 and 16380 for TM1081
and A2DL1, respectively) and the atomic coordinates of the bundles
of 20 conformers used to represent the solution structures of TM1081
and A2DL1 have been deposited in the Protein Data Bank (http://
www.rcsb.org/pdb/) with accession codes 2ka5 and 2kl2, respectively.
2.6. Calculation of reference crystal structures and reference NMR
structures
Reference crystal structures and reference NMR structures were
computed following the strategy introduced in Jaudzems et al. (2010).
For the reference crystal structure, the positions of the H atoms in the
crystal were calculated using the standard residue geometries from
the AMBER94 library in the software MOLMOL (Koradi et al.,
1996). All intra-residual and inter-residual distances shorter than
5.0 A ˚ between pairs of H atoms were then extracted and those
involving labile protons with fast chemical exchange (Wu ¨thrich, 1986)
were eliminated from the resulting list. The input of upper-limit
distance bounds for the structure calculation was generated by
increasing these proton–proton distances by 15%. This ‘loosening’ of
the distance constraints is in line with the basic strategy of inter-
preting
1H–
1H NOEs in terms of upper-limit distance bounds
(Wu ¨thrich, 1986). For the reference NMR structure, we followed a
three-step protocol: (i) a list was prepared of all the
1H–
1H distances
shorter than 5.0 A ˚ in the 20 conformers that represent the NMR
structure, (ii) a new list was obtained that included the longest
distance among the 20 conformers for each pair of H atoms in the list
resulting from (i), and (iii) the input of upper-limit distance bounds
contained all entries in list (ii) that were shorter than 5.75 A ˚ [this
value was empirically selected as the shortest cutoff that gave
virtually identical results for the structure calculation as an input
consisting of the complete list (ii)].
2.7. Calculation of global displacements, global r.m.s.d.s, solvent
accessibility and occluded surface packing (OSP)
The techniques used here have been described in Jaudzems et al.
(2010). The global per-residue displacements between structure
bundles refer to the mean structures calculated after superposition
with minimal r.m.s.d. of the backbone-atom selections indicated in
Tables 1 and 2.
3. Results and discussion
New NMR structures of the proteins TM1081 and A2DL1 are
presented and compared with the crystal structures that have
previously been determined by the JCSG. In the structure compar-
isons, we followed a recently introduced protocol (Jaudzems et al.,
2010; Mohanty et al., 2010), which yielded two initial observations: (i)
overall, the NMR structures of TM1081 and A2DL1 are less precisely
determined than those of other proteins studied using the same
protocol, as quantitated by the global r.m.s.d. values for the entire
polypeptide chains, and (ii) the increased global r.m.s.d. values can be
traced to discrete short polypeptide segments with high per-residue
displacements. These results of the standard comparison protocol
then served to guide us in devising the strategy for more detailed
comparisons in xx3.3–3.5. Speciﬁcally, in combination with the avail-
able functional annotations of TM1081 and A2DL1, the observations
(i) and (ii) revealed that residues in and near the active sites are
strongly represented among the less well deﬁned segments of the
protein structures.
In order to monitor the possible impact of the different software
used by the two techniques for structure calculation and reﬁnement,
we used reference crystal structures and reference NMR structures
computed from the experimental structures, as described in x2.6
(Jaudzems et al., 2010), to support the interpretation of apparent
differences between the experimental NMR and crystal structures.
3.1. NMR structure of TM1081 and functional annotation
The TM1081 structure contains a highly twisted ﬁve-stranded
 -sheet ﬂanked by four  -helices. The regular secondary-structure
elements are arranged in the sequential order  1- 2- 1- 3- 2- 4- 3-
 5- 4 (Fig.1).The  -strands  2,  3,  4 and 5 (residues 11–13, 42–46,
74–78 and 98–100, respectively) are oriented parallel to each other,
whereas  1 (residues 4–6) is antiparallel to  2. The  -helices  1,  2
and  3 (residues 21–34, 55–70 and 82–90, respectively) are on one
side of the  -sheet and  4 (residues 104–110) is on the opposite side.
Statistics of the NMR structure determination are given in Table 1
and those for the crystal structure are available from the PDB (PDB
entry 3f43).
A structure-homology search using the software DALI (Holm et
al., 2008) identiﬁed ten structures with a Z score of  10. All have
been annotated as anti-  factor antagonists, share less than 25%
sequence identity with TM1081 and belong to the SCOP family
SpoIIaa, which includes another T. maritima structure determined by
NMR at the JCSG, TM1442 (Etezady-Esfarjani et al., 2006). The
functional annotation of TM1081 is based on a sequence-homology
search with BLAST, which showed that TM1081 contains a tripeptide
Asp54-Ser55-Phe56 that forms a serine-phosphorylation motif char-
acteristic of anti-  factor antagonists and also contains the following
additional residues that are conserved in other anti-  factor
antagonists: Lys17–Asn23, Ser52, Ile53, Ser57–Ile64, Arg86, Leu90,
Thr91 and Leu93 (Fig. 1c). This analysis was conﬁrmed by a
homology search using the ConSurf server (Ashkenazy et al., 2010)
for the identiﬁcation of functional regions in proteins.
3.2. NMR structure of A2DL1 and functional annotation
The NMR structure of mouse A2DL1 includes seven  -strands
(residues 2–5, 28–36, 42–45, 50–53, 64–70, 89–99 and 109–116), three
 -helices (residues 18–21, 72–81 and 122–125) and one 310-helix
(residues 23–25; the helical secondary-structure elements identiﬁed
in the crystal structure were labeled H1–H4, with H1, H3 and H4
corresponding to  1,  2 and  3 and H2 corresponding to the
310-helix; Klock et al., 2005). The sequential order of the regular
secondary-structure elements is  1- 1–310- 2- 3- 4- 5- 2- 6- 7- 3
(Fig. 2). The structure contains a  -barrel formed by ﬁve strands,
 1- 5- 2- 6- 7, in which strands  1 and  7 are parallel and all other
neighboring strands are antiparallel (Fig. 2a). The barrel is ﬂanked on
one side by helices  1 and  2, which are arranged in the direction of
the barrel axis and are closest to strands  5 and  1, respectively. A
structural communications
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aforementioned  -barrel, where  4 is in contact with it. The C-
terminal segment 126–149 shows no regular secondary structure and
packs against sheet  3– 4. Statistics of the NMR structure determi-
nation are given in Table 2 and those for the
crystal structure have been presented elsewhere
(Klock et al., 2005).
As described above, the functional annotation
of mouse A2DL1 as a  -glutamylamine cyclo-
transferase was based on comparison with the
highly homologous human enzyme (Oakley et al.,
2010). The catalytic site of A2DL1, consisting of
Tyr7, Gly8, Thr9, Leu10, Ile50, Glu82, Tyr88,
Tyr115 and Tyr143 (Fig. 2c), was identiﬁed based
on complete conservation with respect to the
human homolog. A ConSurf search (Ashkenazy
et al., 2010) for the identiﬁcation of functional
regions shows complete conservation for all
catalytic residues, with the sole exception that, in
two species, Thr9 is replaced by either Ser or Ala.
3.3. Global comparisons of the respective NMR
and crystal structures of TM1081 and A2DL1
Following the observations described at the
outset of x3, we followed a strategy of ﬁrst
comparing the well deﬁned polypeptide segments
with per-residue displacements below the mean
values for the entire polypeptide chains, 0.50 A ˚
for TM1081 and 0.64 A ˚ for A2DL1, which in both
proteins comprise about 65% of all residues
(brown in Figs. 1b and 2b). Since this well deﬁned
part of the molecular structures will serve as a
reference for the conclusions about the less well
structured residues, we will ﬁrst summarize the
observations made on these scaffolds. We will
then analyze the respective behavior of the less
well behaved residues that are either part of the
active-site regions or spatially separated from
them.
For both TM1081 and A2DL1, the global
r.m.s.d.s calculated for all residues with below-
average displacements are similar to those
reported for the previously analyzed proteins
NP_247299.1 (Jaudzems et al., 2010), TM1112 and
TM1367 (Mohanty et al., 2010) (Figs. 3 and 4).
The results for the well deﬁned protein scaffolds
conﬁrm the conclusions drawn from these earlier
comparisons of NMR and crystal structures. (i)
The backbone folds in the corresponding NMR
and crystal structures can be overlapped with
r.m.s.d. values of about 1.0 A ˚ (Figs. 3 and 4). (ii)
While the r.m.s.d. values for the backbone heavy
atoms in the crystal structure are essentially
identical to those for all heavy atoms, the r.m.s.d.s
for the corresponding selections of atoms in the
reference crystal structure differ by nearly
twofold, similar to the NMR structure and the
reference NMR structure (Figs. 3 and 4). (iii)
Although the side-chain torsion angles show high
variability in the NMR structures (Figs. 5 and 6),
the packing density is closely similar to the corresponding crystal
structures (Figs. 7 and 8).
Whereas very similar observations were made and near-identical
quantitative results were obtained from comparison of those parts of
structural communications
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Figure 1
NMR structure of TM1081 and comparison with the crystal structure. (a) Stereo ribbon diagram of the
NMR conformer closest to the mean coordinates of the bundle of conformers in (b). Color code:  -strands,
cyan; helices, red/yellow; nonregular secondary structure, gray. The individual regular secondary structures
are labeled and the N- and C-termini are indicated. (b) Stereoview of a superposition for best ﬁt of the
polypeptide-backbone heavy atoms of residues 3–110 of the crystal structure (black line) with the bundle of
20 conformers that represent the NMR structure. Color code used for the NMR structure: brown, residues
with DNMR   0.50 A ˚ , which is the mean value of the global per-residue displacements in the entire protein;
green, residues with DNMR >0 . 5 0A ˚ .( c) Amino-acid sequence of the construct used for the NMR structure
determination. Black letters represent residues with DNMR   0.50 A ˚ and green letters those with DNMR >
0.50 A ˚ . The N-terminal segment indicated in italics originates from the expression and puriﬁcation tag; it
was present during the NMR measurements, but is not part of the TM1081 protein and is not shown in (a)
and (b). Underlined residues were identiﬁed as being conserved in anti-  factor antagonists (see text) in a
sequence-homology search by BLAST and were subsequently conﬁrmed using the ConSurf server
(Ashkenazy et al., 2010). Black dots indicate residues for which no backbone amide resonances were
observed in the 2D [
15N,
1H]-HSQC spectrum. Above the sequence, cyan arrows indicate the positions of
the  -strands and red bars those of the  -helices in the NMR structure.the two proteins that are made up of residues
with below-average displacements in the NMR
structures, quite different insights resulted from
analysis of the remaining less well structured
parts of the two proteins. Therefore, the results
obtained for TM1081 and A2DL1 are presented
in separate sections below.
3.4. Analysis of the molecular regions of
TM1081 with increased disorder in the NMR
structure and implications for the putative
functional binding site
In TM1081, the polypeptide segments with per-
residue displacements above the mean value of
0.50 A ˚ in the NMR structure consist of 39 resi-
dues, Met1–Pro3, Pro15–His25, Asn37–Gly39,
Ser48–Ser55, Ser69–Gly72, Pro80–Glu82, Ser89–
Asn92 and Arg111–Lys113 (green in Fig. 1b),
which represent 35% of the polypeptide chain.
Among the 22 residues that are conserved in
other anti-  factor antagonists (Fig. 1c), 14 resi-
dues, 17–24, 52–55 and 90–91, are located within
these less well deﬁned areas of the NMR struc-
ture and these will now be more closely analyzed.
The largest DNMR values are observed for the
conserved segment Lys17–Asn23 at the start of
helix  1, which is precisely structured in the
crystal and also has low DRefCrystal values (Fig. 9).
Similarly, the large DNMR values observed for
some residues in the segment 47–64, which
comprises residues 47–51 that are in spatial
contact with the conserved segment 17–23 and
the conserved residues 52–64, contrast with their
high deﬁnition in the crystal and reference crystal
structures. The segment 77–95 with the conserved
residues Arg86, Leu90, Thr91 and Leu93 also
shows large displacements in solution that have
no counterpart in the crystal structure. The low
precision in segment 17–24 is also reﬂected in the
large dihedral angle variations among the 20
conformers of the NMR structure, with six out of
seven residues showing variations that exceed
 60  (Fig. 5). In the other disordered conserved
segments 52–55 and 90–91, all backbone dihedral
angles are well deﬁned in the NMR structure. In
plots of the occluded surface packing (OSP;
Pattabiraman et al., 1995), the four experimental
and reference structures display similar proﬁles,
except that the conserved segments 17–21 and
52–58 show lower packing density in the NMR
structure (Fig. 7). Overall, although the atomic
coordinates of the mean NMR and crystal
structures of TM1081 coincide closely
throughout, increased structural disorder is
manifested in the NMR data for a majority of the residues directly
related to protein function (Figs. 5, 7 and 9).
It is well known that the binding of anti-  factor antagonists is
modulated by phosphorylation of a Ser residue (Ser55 in TM1081),
but their mechanism of action remains elusive. Comparison of the
crystal structures of the free and phosphorylated forms of the anti- 
factor antagonist SpoIIAA from Bacillus subtilis shows that, in
contrast to other kinase-regulated protein families, phosphorylation
does not seem to induce large conformational changes in the protein
architecture (Seavers et al., 2001). Similarly, substitution of the active
Ser by an acidic residue does not mimic the effect of phosphorylation.
High structure similarity was also found between the NMR structures
of the free and phosphorylated forms of TM1442 (Etezady-Esfarjani
et al., 2006), in which the free form was extremely sensitive to
structural communications
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Figure 2
NMR structure of the protein A2LD1 and comparison with the crystal structure. The same presentation is
used as in Fig. 1, but the following should be noted. In (b), the polypeptide-backbone heavy atoms of
residues 2–100 and 106–144 were superimposed for best ﬁt. The residues with global displacements DNMR >
0.64 A ˚ are indicated by blue coloring in (b) and are represented by blue letters in (c). In (c), residues
forming the catalytic site are underlined (see text).variations in salt concentration and pH, while the phosphorylated
form was more stable in solution. These observations have been
interpreted as an indication that the role of the phosphate group is
not limited to steric or electrostatic interference (Kovacs et al., 1998),
but also induces local structure rearrangements in the binding region
(Seavers et al., 2001).
In TM1081, the anti-  factor binding region consists primarily of
residues 17–23 and 52–55, as identiﬁed by structure homology with
other anti-  factor antagonists (Kovacs et al., 1998; Etezady-Esfarjani
et al., 2006; Seavers et al., 2001). Line broadening of amide-group
signals in NMR spectra recorded at 313 K (Fig. 10) manifests con-
formational exchange on the millisecond time scale for Asn16, Glu22,
His25, Leu26, Phe27, Ser52–Ser55, Ser68 and Ser69. This confor-
mational exchange involves large variations of the backbone in the
segment Lys17–Ile23, which results in several charged side chains
being oriented differently in solution and in the crystal (Fig. 11). In
particular, whereas in the crystal structure the carboxyl group of
Glu18 forms a hydrogen bond to the amide group of Ser52, it is
exposed to the solvent in the NMR structure; also, the Lys17 side-
chain hydrogen bond to the side-chain amide of Asn16 is not seen in
the NMR structure, in which Lys17 is oriented towards Asp49. By
analogy to the SpoIIAB–SpoIIAA complex, in which the crystal
structure indicates that electrostatic interactions are fundamental for
complex formation (Masuda et al., 2004), the local rearrangement of
charged residues may play an important role in modulating the afﬁ-
nity of TM1081 for the corresponding anti-  factor.
Among the 25 nonconserved positions with DNMR >0 . 5 0A ˚ ,1 2
residues are located sequentially adjacent to conserved amino acids,
with Pro15, Asn16 and His25 ﬂanking the binding-site region Lys17–
Ala24, segment Ser48–Glu51 preceding the conserved segment 52–64
and Ser89 and Asn92 ﬂanking the conserved dipeptide Leu90–Thr91.
structural communications
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Figure 4
Global comparison of the crystal and NMR structures of A2LD1. The same
presentation is used as in Fig. 3. For the computation of the global r.m.s.d.s the
structures were superimposed for best ﬁt of the backbone heavy atoms of residues
2–144. In (c), r.m.s.d.s were calculated for residues with DNMR   0.64 A ˚ (see text).
Figure 3
Global comparisons of the NMR structure, the crystal structure and the reference
NMR and reference crystal structures of TM1081. (a) Global r.m.s.d. values for the
NMR structure, the reference NMR structure and the reference crystal structure.
The atoms used for the comparisons are bb, backbone atoms N, C
  and C0; co, core
heavy atoms deﬁned as having less than 15% solvent accessibility; ha, all heavy
atoms. For the computation of the global r.m.s.d. values the structures were
superimposed for best ﬁt of the backbone heavy atoms of residues 3–110. For the
crystal structure, we calculated an apparent global r.m.s.d. value from the per-
residue displacements, which were linked to the crystallographic B values through
an empirical scaling factor (Jaudzems et al., 2010) to ensure a close match with the
corresponding displacementvaluesinthereferencecrystalstructure(seealsoFigs.9
and 13 below). For the structure comparisons, r.m.s.d. values were computed
between the crystal structure coordinates and those of the conformer closest to the
mean atom coordinates of each of the three ensembles of 20 conformers that
represent the NMR structure and the two reference structures. Numbers framed by
thick lines show the precision of the experimental structures, those with medium
frames show the precision of the reference NMR and reference crystal structures
and their comparison and those with thin frames show comparisons between
experimental and reference structures. (b) Comparison of the NMR and crystal
structures, with r.m.s.d.s calculated for best ﬁt of the segment 3–110. (c) The same as
(b) with r.m.s.d.s calculated for the residues with DNMR values   0.50 A ˚ (see text).structural communications
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Figure 6
Backbone dihedral angles and side-chain torsion angles in the crystal structure of A2LD1 and comparisons with the NMR, reference NMR and reference crystal structures.
The same presentation is used as in Fig. 7. Shading highlights the active-site residues, as in Fig. 13(b).
Figure 5
Backbone dihedral angles and side-chain torsion angles in the crystal structure of TM1081 and comparison with the NMR, reference NMR and reference crystal structures.
(a–c) Spread of the values for the backbone dihedral angles ’ and   in the bundles of 20 conformers representing the NMR structure (a), the reference NMR structure (b)
and the reference crystal structure (c). In this presentation, the mean value in the bundles of 20 conformers is at 0 , the blue vertical bars represent the spread of the values
within the bundles and the red dots indicate the deviation of the crystal structure values from the corresponding mean values for the bundle of 20 conformers. (d–f) Spread of
the values for the amino-acid side-chain torsion angles,  1 and  2, in the NMR structure (d), the reference NMR structure (e) andthe reference crystal structure (f). The same
presentations are used as in (a)–(c). At the top of the two panels, the locations of the regular secondary structures are indicated and asterisks identify the residues with
solvent accessibility below 15% in the NMR structure. Shading indicates the conserved residues in anti-  factor antagonists, as in Fig. 9(b).In addition, segment 80–82 is spatially close to Val50 and Glu51 near
the binding site. The large DNMR values for these residues contrast
with low hxi values in the crystal, similar to the observations for the
conserved residues. An additional seven residues are in two solvent-
exposed loops far from the binding site, i.e. 37–39 and 69–72, and six
residues are at the chain termini. All of these residues have similar
global displacements in the NMR and crystal structures.
In conclusion, in contrast to the chain termini and some solvent-
exposed loops, which display expected structural disorder in solution
and in the crystal, conserved binding-site segments and ﬂanking
residues that form the overall catalytic site display ‘nontrivial’,
potentially function-related, disorder in the NMR structure. The
solution structure and supplementary NMR data show that the
binding site in the unliganded form of TM1081 undergoes slow
conformational transitions on the millisecond time scale, which would
allow local rearrangements triggered by functional modiﬁcation of
Ser55. This conformational plasticity of the unliganded form might be
even more pronounced at the optimal growth temperature of 353 K
structural communications
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Figure 9
Local precision of the TM1081 structures along the sequence. (a) Linear least-
squares ﬁt of the crystallographic per-residue B values versus the corresponding
per-residuedisplacementsinthereferencecrystalstructure,DRefCrystal,yieldingc=1/
69 in equation (3) of Jaudzems et al. (2010). (b) Plots of the per-residue
polypeptide-backbone displacements versus the sequence. Upper panel, crystal
structure and reference crystal structure. Lower panel, NMR structure and
reference NMR structure. For the crystal structure, per-residue displacements were
calculated from the B values using the relation in (a). For the NMR structure and
the two reference structures the data correspond to the global per-residue
displacements calculated for bundles of 20 conformers (Billeter et al., 1989). The
locations of regular secondary structures are indicated in the upper panel and
conserved residues in anti-  factor antagonists are shaded (see text).
Figure 8
Occluded surface packing along the polypeptide chain of A2LD1. The same
presentation is used as in Fig. 7. Shading identiﬁes the active-site residues, as in
Fig. 13(b).
Figure 7
Surface packing along the polypeptide chain of TM1081. (a)Plots versus the amino-
acid sequence of the per-residue occluded surface packing (OSP, a dimensionless
quantity covering the range from 0.0 to 1.0; Pattabiraman et al., 1995) for the NMR
(red), crystal (blue), reference NMR (green) and reference crystal (black)
structures. For the NMR structure and the two reference structures, the OSP
values for the conformer closest to the mean atom coordinates of the bundles are
shown. At the top, the locations of the regular secondary structures are indicated
and asterisks identify the residues with solvent accessibility below 15% in the NMR
structure. (b) Plot versus the amino-acid sequence of the mean per-residue OSP
values in the NMR structure and the standard deviations among the 20 NMR
conformers. Shading indentiﬁes the conserved residues in anti-  factor antagonists,
as in Fig. 9(b).for T. maritima and the concomitant variation of
the local electrostatic charge distribution might
modulate and even prevent the binding of the
anti-  factor to the nonphosphorylated form of
TM1081, as previously proposed for other anti- 
factor antagonists (Kovacs et al., 1998).
3.5. Analysis of the molecular regions of A2DL1
with increased disorder in the NMR structure
and implications for the active-site conformation
and functional mechanisms
In A2DL1, the following 46 positions have per-
residue displacements DNMR above the mean
value of 0.64 A ˚ : 1–3, 7–13, 24, 47, 79–82, 84, 102–
106, 119–123, 126 and 133–149 (highlighted in
blue in Figs. 2b and 2c). These include six of the
nine catalytic site residues, i.e. Tyr7, Gly8, Thr9,
Leu10, Glu82 and Tyr143 (Fig. 2c). For these
residues, we observe large per-residue NMR
displacements which contrast with low B values in
the crystal structure. Of special interest is the
structural disorder of the active-site residues
Tyr7, Gly8 and Thr9 in the unliganded protein
(Fig. 12a), since these residues form hydrogen
bonds to the substrate in the crystal structure of
GGACTand to formate in the crystal structure of
A2DL1 (Fig. 12b). These interactions are funda-
mental for catalysis, as described in detail by
Oakley et al. (2010). The three additional active-
site residues, Ile50, Tyr88 and Tyr115, have high
structural deﬁnition in the NMR structure, with
similar side-chain orientations as in the crystal
structures of A2DL1 and GGACT (Fig. 12).
Among the other 39 positions with DNMR >
0.64 A ˚ , 18 residues (11–13, 79–81, 84, 133–142
and 144) form a cavity surrounding the active site
(Fig. 2b), where they show similar structural
characteristics as the disordered active-site resi-
structural communications
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Figure 11
Putative activesite in TM1081. (a) Stereo ribbon representation of the same NMR conformer as in Fig.1(a)
after subsequent rotations by 90  about a horizontal axis and 180  about a vertical axis. (b) and (c) show
stereoviews of structural details with the same viewing angle. (b) Polypeptide segments 16–26, 49–55 and
88–92 in the crystal structure, which form the putative binding site of TM1081 (see text). (c) Bundle of 20
NMR conformers for the same segments as in (b).
Figure 10
NMR evidence for slow local conformational exchange in the NMR structure of TM1081. (a)2 D[
15N,
1H]-HSQC spectrum of a 1.0 mM solution of uniformly
15N-labeled
TM1081 recorded at 800 MHz and 313 K. The cross-peaks shown in (b) are identiﬁed. (b) Cross-sections along !2(
1H) through the cross-peaks identiﬁed with the
corresponding color code in (a).dues, with high DNMR values and small crystal B values (Fig. 13b). The
common behavior of the residues in the active site and in the
surrounding cavity extends to protein mobility. In the 2D [
15N,
1H]-
HSQC spectrum of A2DL1 (Fig. 14a), signals with outstanding
intensities are indicated and cross-sections of these peaks are shown
in Figs. 14(b) and 14(c). Variations in the relative peak intensities
arise from dependence of the NMR line shapes on local intramole-
cular mobility. In Fig. 14, residues Asp22 and Gly58 represent line
shapes that are not visibly affected by local motions. Fig. 14(b) shows
that Tyr7, Thr9, Leu10 and Tyr115 in the catalytic cavity exhibit lower
peak intensities than Asp22 and Gly58, indi-
cating that they are subject to slow conforma-
tional exchange on the millisecond time scale.
Comparable low-frequency mobility has
previously been reported in many instances for
residues located in catalytic sites (Wang et al.,
2001; Schnell et al., 2004; Boehr et al., 2006) and
has also been correlated with ligand binding in
T4 lysozyme (Mulder et al., 2000).
The 21 residues with DNMR >0 . 6 4A ˚ that are
located outside of the catalytic cavity form the
two chain termini 1–3 and 145–149 and other
solvent-exposed areas far from the catalytic
cavity (Figs. 2b and 2c). They all show poor
structural deﬁnition in both NMR and crystal
structures, with similar per-residue global
displacement proﬁles (Fig. 13b). For Gly104 and
Asp105 in a surface loop located far from the
catalytic site and not modeled in the crystal
structure (Fig. 13b), we observed very high peak
intensities with respect to Asp22 and Gly58, and
15N{
1H}-NOE measurements (data not shown)
conﬁrmed that this is a consequence of fast
motion on the subnanosecond time scale.
In summary, a number of active-site and
catalytic cavity residues display structural
disorder in solution that is not correlated with
disorder in the crystal. Supplementary NMR data
further show that these residues undergo
conformational exchange on the millisecond time
scale, which might support controlled access of
the substrate. Similar to TM1081, the conforma-
tional features of residues in and near the active
site are clearly different from the ‘trivial
disorder’ seen in solution, as well as in the
structural communications
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Figure 12
Catalytic site of the mouse  -glutamylamine cyclotransferase A2LD1. (a) Catalytic site residues of A2LD1
represented by a bundle of the ﬁve lowest-energy NMR conformers. Cyan coloring highlights residues that
form hydrogen bonds with the ligands in the crystal structures. (b) Superposition of the crystal structures of
A2LD1 in complex with formate (green) and human GGACTin complex with 5-oxo-l- -proline (magenta;
PDB code 3juc; Oakley et al., 2010). The two structures were superimposed for best ﬁt of the polypeptide
heavy atoms shown in the drawing, yielding an r.m.s.d. of 0.62 A ˚ . The ligands are shown inside the dotted
line as yellow carbon skeletons and otherwise with standard colors for O and N atoms. The black residue
numbers are for A2LD1. Owing to an insertion, the two highest residue numbers shown in the ﬁgure for
GGACT are different, as indicated in magenta.
Figure 13
Local precision of the A2LD1 structures along the sequence. The same presentation is used as in Fig. 9. Residues of the A2LD1 active site are shaded (see text).crystals, for the polypeptide-chain termini and some peripheral
surface areas distant from the active site.
4. Concluding remarks
There is no paucity of investigations on protein structural order/
disorder and dynamics in the literature. Generally, publications in this
ﬁeld focus on individual targets and, for many of these proteins, an
admirable wealth of detailed data has been accumulated (for recent
illustrations, see Boehr et al., 2010; Fraser et al., 2009). In this paper,
we use a protocol of systematic comparisons of corresponding
structures in solution and in the crystal to investigate possible
correlations of structural order and dynamics with the characteristics
of the binding sites of two globular proteins. The results in the
preceding sections show that the reactive areas in these two func-
tionally annotated proteins could have been recognized from
increased structural disorder and slow dynamic processes that were
observed only in solution. The protein A2DL1 actually provides a
striking illustration of the complementarity of relevant information
collected either from the crystal or in solution; while NMR studies of
the unliganded protein showed pronounced disorder for some active-
site side chains, these same side chains are well ordered in the crystal
structure of the ‘unliganded protein’. This different behavior can be
rationalized by the observation in the crystal structure that the
position of the substrate is occupied by a component of the buffer
solution and that the spatial arrangement ofthe active-site side chains
in the nonspeciﬁc complex mimics the orientation of those in the
crystal structure of the homologous protein GGACTin complex with
a substrate mimic. For future challenges of analyzing domains of
unknown function (DUFs) with a known three-dimensional structure,
the indication from the data presented here is that polypeptide
segments that are differently structured in solution and in the crystal
might be a ﬁrst step toward obtaining function-related insights, such
as identiﬁcation of their active sites. Conformational exchange on the
millisecond time scale for certain residues in the active site of unli-
ganded proteins further suggests that such internal mobility, in
contrast to much faster elemental thermal motions (Boehr et al.,
2010), must involve concerted movements of a large number of atoms
with activation energies of the order of 50 kJ mol
 1 and might be
important for selective interactions with their reaction partners.
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Figure 14
NMR evidence for local conformational exchange inthe NMR structure of A2LD1.
(a)[
15N,
1H]-HSQC spectrum of a 1.1 mM solution of A2LD1 recorded at 700 MHz
and 298 K. The cross-peaks of residues shown in (b) and (c) are identiﬁed. (b)
Cross-sections along !2(
1H) through cross-peaks of active-site residues with low-
frequency mobility (see text), as identiﬁed with the corresponding color code in (a).
(c) The same as (b) for residues with high-frequency mobility (see text).American Type Culture Collection (ATCC; ATCC ID 435895-D and
ATCC ID 5100366, respectively). The content is solely the respon-
sibility of the authors and does not necessarily represent the ofﬁcial
views of the National Institute of General Medical Sciences or the
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